Monday, May 03, 2021 5:42:49 PM
$BPSR New Video Digital Transformation In Cell Therapy with Organicell Drs. Mari Mitrani & Michael Bellio
Published on May 3, 2021
Drs. Mari Mitrani, CSO and Michael Bellio, Laboratory Director are young pioneers in the study of the therapeutic potential of exosomes. Their research leans heavily into the digital realm, leveraging computational biology, bioinformatics, large-scale sequencing, proteomics, and mass spectrometry to analyze perinatal tissue-secreted exosomes and their impact on a host of indications the company is exploring. On this episode of The Business Of Biotech, Drs. Mitrani and Bellio offer insight into the digital discovery and manufacturing automation technologies in use at Organicell.
Published on May 3, 2021
Drs. Mari Mitrani, CSO and Michael Bellio, Laboratory Director are young pioneers in the study of the therapeutic potential of exosomes. Their research leans heavily into the digital realm, leveraging computational biology, bioinformatics, large-scale sequencing, proteomics, and mass spectrometry to analyze perinatal tissue-secreted exosomes and their impact on a host of indications the company is exploring. On this episode of The Business Of Biotech, Drs. Mitrani and Bellio offer insight into the digital discovery and manufacturing automation technologies in use at Organicell.
Recent ZEOX News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/09/2026 11:16:04 AM
- Regen Therapy Partners with Stealth Health to Bring Specialized Telemedicine Services and Longevity Programs to 3,000 Clinics - Powered by an Exclusive Scientific and Biologics Strategic Collaboration with ZEO ScientifiX (OTCQB:ZEOX) • ACCESS Newswire • 04/09/2026 11:00:00 AM
- ZEO ScientifiX (OTCQB: ZEOX) Selected as Qualified Team Advancing into the XPRIZE Healthspan Semi-Finals Stage • ACCESS Newswire • 04/07/2026 05:56:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 11:50:14 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/31/2026 12:15:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/27/2026 08:05:13 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 03/17/2026 08:17:09 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 02/06/2026 11:54:56 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 01/29/2026 09:05:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/28/2026 11:01:57 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/21/2026 10:17:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/16/2026 09:05:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/16/2026 09:05:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/07/2026 01:00:48 PM
- Cytora Therapeutics, Made Scientific, and Zeo ScientifiX Announce Partnership to Manufacture and Commercialize Cytora's Allogeneic Stem Cell Therapy in the United States • ACCESS Newswire • 01/07/2026 12:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2026 11:02:17 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/03/2025 09:05:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/23/2025 12:30:32 PM
- ZEO ScientifiX(TM) Positioned for New Growth as Florida Opens Stem Cell Market • ACCESS Newswire • 10/23/2025 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/15/2025 08:15:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/29/2025 08:05:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/21/2025 08:05:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/09/2025 12:45:20 PM
